Skip to Main Content

Author Details

Joel M Baumgartner
University of California
2007
81
24
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37436640Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases.J Gastrointest Cancer2024
37806228Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy.J Surg Res2024
36305990Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?Ann Surg Oncol2023
37666090Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal Cancer.J Surg Res2023
37620532Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.Ann Surg Oncol2023
37423927ASO Visual Abstract: Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Multi-institutional Analysis.Ann Surg Oncol2023
37294386Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis.Ann Surg Oncol2023
36477643Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis.Surg Endosc2023
36468401Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.J Surg Oncol2023
36369408ASO Visual Abstract: Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?Ann Surg Oncol2023
36367628ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC.Ann Surg Oncol2023
34506026Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative.J Gastrointest Surg2022
35849291Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.Ann Surg Oncol2022
36571414Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens.J Vis Exp2022
36102565Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial.J Am Coll Surg2022
36067351An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape.Clin Cancer Res2022
36064993ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.Ann Surg Oncol2022
33002202A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.J Surg Oncol2021
33905776Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.Hum Pathol2021
33845460NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.J Natl Compr Canc Netw2021
33507449Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.Ann Surg Oncol2021
33634422The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative.J Gastrointest Surg2021
34994628Palbociclib as a Novel Therapy for Low-Grade Mucinous Carcinomatosis Peritonei of Appendiceal Origin.JCO Precis Oncol2021
33465587A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies.Surg Oncol2021
33415564A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms.Ann Surg Oncol2021
31428960Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative.J Gastrointest Surg2020
31745888Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study.J Gastrointest Surg2020
31659645Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?Ann Surg Oncol2020
31974019What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative.Clin Colorectal Cancer2020
33270763Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.PLoS One2020
33073341CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.Ann Surg Oncol2020
33040617The impact of HIPEC <i>vs.</i> EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative.Int J Hyperthermia2020
32864043Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative.World J Gastrointest Oncol2020
32767050Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.Ann Surg Oncol2020
32627199Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.J Surg Oncol2020
32622162Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.J Surg Res2020
32696303Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative.Ann Surg Oncol2020
32303875ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.Ann Surg Oncol2020
32164300Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review.J Clin Med2020
32318945Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.Ann Surg Oncol2020
31558307Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Am J Surg2020
30815802Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?Ann Surg Oncol2019
30132292Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma.J Gastrointest Surg2019
31576472ASO Author Reflections: Venous Thromboembolism after CRS/HIPEC.Ann Surg Oncol2019
31190209Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer.Ann Surg Oncol2019
31016486Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.Ann Surg Oncol2019
31065960Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol2019
29090402Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol2018
32913983Genomic Landscape of Appendiceal Neoplasms.JCO Precis Oncol2018
29948422Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival.Ann Surg Oncol2018
  • 1 - 50 of 81

Recommended Authors

Ian Solsky
Wake Forest University
Career Start Year 2015
Number of shared co-authors 0
Alex B Blair
Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Ian W Folkert
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
Nazim Benzerdjeb
Institut de Pathologie Multisite
Career Start Year 2013
Number of shared co-authors 0
Hiroyuki Horiguchi
National Defense Medical College
Career Start Year 2012
Number of shared co-authors 0
Nicholas Brian Shannon
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Patricio M Polanco
University of Texas Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 1
Samuel Eisenstein
University of California San Diego
Career Start Year 2004
Number of shared co-authors 2
Rebecca C Auer
The Ottawa Hospital Research Institute
Career Start Year 2002
Number of shared co-authors 0
Brian A Costello
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 2
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
Scott Kopetz
University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 6
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Isabelle Ray-Coquard
University Claude Bernard Lyon I
Career Start Year 1997
Number of shared co-authors 0
Antonio Cubillo
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 0
Helgi Birgisson
The Icelandic Cancer Registry
Career Start Year 1997
Number of shared co-authors 0
Victor M Zaydfudim
Surgical Outcomes Research Center, University of Virginia
Career Start Year 1996
Number of shared co-authors 0
Alexandra M Easson
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Hideki Ueno
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 1
John M Kane
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 2
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 1
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 1
Richard J Barth
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 0
Steven R Alberts
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 2
Al B Benson
Northwestern University Feinberg School of Medicine
Career Start Year 1984
Number of shared co-authors 8
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 2
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Andrew M Lowy
University of California San Diego
Co-authored papers 30
Martin D McCarter
University of Colorado School of Medicine
Co-authored papers 7
Rebecca A Marmor
12220University of California San Diego
Co-authored papers 4
Syed A Ahmad
University of Cincinnati College of Medicine
Co-authored papers 4
Mark A Valasek
Co-authored papers 4
Lisa Madlensky
Department of Medicine and Moores Cancer Center, University of California San Diego.
Co-authored papers 3
Olivier Harismendy
University of California
Co-authored papers 3
Paul T Fanta
University of California San Diego Moores Cancer Center
Co-authored papers 3
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 2
Erin Ward
Boston Children's Hospital
Co-authored papers 2
Christopher C Silliman
Vitalant Research Institute
Co-authored papers 2
Santiago González-Moreno
Co-authored papers 2
Sonia Ramamoorthy
University of California
Co-authored papers 2
Karen Messer
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 2
Rene Gonzalez
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Beatrice J Edwards
Central Texas Veterans Healthcare System
Co-authored papers 1
Anna Weiss
Co-authored papers 1
Michael A Liss
University of Texas Health San Antonio
Co-authored papers 1
Daniel T Laskowitz
Duke University
Co-authored papers 1
Maria Elena Martinez
Co-authored papers 1
Celina Ang
Tisch Cancer Institute, Mount Sinai Hospital
Co-authored papers 1
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 1
Michael Bouvet
Co-authored papers 1
David Xu
Co-authored papers 1
John Paul Shen
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Co-authored papers 1
June M McKoy
Feinberg School of Medicine, Northwestern University
Co-authored papers 1
Bruno C Medeiros
AbbVie Inc.
Co-authored papers 1
Ann Tipps
University of California San Diego
Co-authored papers 1
Florin Vaida
School of Public Health, university of california san diego
Co-authored papers 1
Release 1.2